Skip to main content
SpringerLink
Log in

Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis

  • Articles
  • Ciprofloxacin: Clinical Experience
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

Eighty hospital patients with acute purulent exacerbations of chronic bronchitis associated withHaemophilus influenzae, Streptococcus pneumoniae, Branhamella catarrhalis orPseudomonas aeruginosa were treated with ciprofloxacin. The patients were divided into four groups of 20 patients each and administered either 500 mg, 750 mg (two different batches of tablets) or 1000 mg twice daily for ten days. Most of the patients withHaemophilus influenzae andBranhamella catarrhalis infections were treated successfully but the results in patients withStreptococcus pneumoniae andPseudomonas aeruginosa infections were less satisfactory. Although the ciprofloxacin MICs for the latter organisms were relatively low, mean serum and sputum concentrations measured on the first day of treatment did not exceed 2–3 mg/l and 1–2.3 mg/l respectively. The overall clinical results for all dosage regimes were only fair, mainly due to failure to eradicateStreptococcus pneumoniae andPseudomonas aeruginosa. Adverse effects (nausea, stomach pain or hallucinations) were seen in eight patients, causing treatment to be discobtinued in five. It is concluded that ciprofloxacin is only of limited use in the treatment of respiratory tract infections unlessStreptococcus pneumoniae is absent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bauernfeind, A., Petermüller, C.: In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. European Journal of Clinical Microbiology 1983, 2: 111–115.

    Article  PubMed  CAS  Google Scholar 

  2. Fass, R. J.: In vitro activity of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1983, 24: 568–574.

    PubMed  CAS  Google Scholar 

  3. Muytjens, H., van der Ros-van de Repe, J., van Veldhuizen, G.: Comparative activities of ciprofloxacin (Bay 09867), norfloxacin, pipemidic acid, and nalidixic acid. Antimicrobial Agents and Chemotherapy 1983, 24: 302–304.

    PubMed  CAS  Google Scholar 

  4. Wise, R., Andrews, J. M., Edwards, L. J.: In vitro activity of Bay 09867, a new quinolone derivative, compared with those of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559–564.

    PubMed  CAS  Google Scholar 

  5. Davies, B. I., Maesen, F. P. V., Teengs, J. P.: Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study. Journal of Antimicrobial Chemotherapy 1984, 14, Supplement C: 83–89.

    PubMed  Google Scholar 

  6. Maesen, F. P. V., Davies, B. I., Teengs, J. P.: Pefloxacin in acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy 1985, 16: 379–388.

    PubMed  CAS  Google Scholar 

  7. Medical Research Council: Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet 1965, i: 775–779.

    Google Scholar 

  8. Mulder, J., Goslings, W. R. O., van der Plas, M. C., Lopez Cardozo, P.: Studies on the treatment with antibacterial drugs of acute and chronic bronchitis caused byHaemophilus influenzae. Acta Medica Scandinavica 1952, 143: 32–49.

    Article  PubMed  CAS  Google Scholar 

  9. Cowan, S. T., Steele, K. J.: Identification of medical bacteria. Cambridge University Press, London, 1974.

    Google Scholar 

  10. Garrod, L. P., Lambert, H. P., O'Grady, F.: Antibiotic and Chemotherapy. Churchill Livingstone, Edinburgh, 1981, p. 464–478.

    Google Scholar 

  11. Davies, B. I., Maesen, F. P. V., Brouwers, J.: Cefoperazone in acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy 1982, 9: 149–155.

    CAS  PubMed  Google Scholar 

  12. Davies, B., Maesen, F.: Serum and sputum antibiotic levels after ampicillin, amoxycillin and bacampicillin in chronic bronchitis patients. Infection 1979, 7, Supplement 5: 465–468.

    Article  Google Scholar 

  13. Wijnands, W. J. A., Van Herwaarden, C. L. A., Vree, T. B.: Enoxacin raises plasma theophylline concentrations. Lancet 1984, ii: 108.

    Article  Google Scholar 

  14. Maesen, F. P. V., Teengs, J. P., Baur, C., Davies, B. I.: Quinolones and raised plasma concentrations of theophylline. Lancet 1984, ii: 530.

    Article  Google Scholar 

  15. Davies, B. I., Maesen, F. P. V., Brombacher, P. J., Sjövall, J.: Twice daily dosage of bacampicillin in chronic bronchitis: a double blind study. Scandinavian Journal of Respiratory Diseases 1978, 59: 249–256.

    PubMed  CAS  Google Scholar 

  16. Davies, B. I., Maesen, F. P. V.: The diagnosis and treatment of respiratory infections. In: Brumfitt, W., Hamilton-Miller, J. M. T. (ed.): A clinical approach to progress in infectious diseases. Oxford University Press, Oxford, 1983, p. 132–158.

    Google Scholar 

  17. Wise, R.: The activity of quinolones against respiratory tract pathogens. In: Shah, P. M. (ed.): Quinolones bulletin. M. I. Publications, Frankfurt, 1985, p. 1–2.

    Google Scholar 

  18. Reeves, D. S., Bywater, M. J., Holt, H. A., White, L. O.: In vitro studies with ciprofloxacin, a new 4-quinolone compound. Journal of Antimicrobial Chemotherapy 1984, 13: 333–346.

    PubMed  CAS  Google Scholar 

  19. Barry, A. L., Jones, R. N.: Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin and oxolinic acid after in vitro selection of resistant populations. Antimicrobial Agents and Chemotherapy 1984, 25: 775–777.

    PubMed  CAS  Google Scholar 

  20. Crook, S. M., Selkon, J. B., McLardy-Smith, P. D.: Clinical resistance to long-term oral ciprofloxacin. Lancet 1985, i: 1275.

    Article  Google Scholar 

  21. Chapman, S. T., Speller, D. C. E., Reeves, D. S.: Resistance to ciprofloxacin. Lancet 1985, ii: 39.

    Article  Google Scholar 

  22. Editorial: The quinolones. Lancet 1984, i: 24–25.

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, De Wever Ziekenhuis, 6401, CX Heerlen, The Netherlands

    B. I. Davies

  2. Department of Respiratory Diseases, De Wever Ziekenhuis, 6401, CX Heerlen, The Netherlands

    F. P. V. Maesen & C. Baur

Authors
  1. B. I. Davies
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. P. V. Maesen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Baur
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davies, B.I., Maesen, F.P.V. & Baur, C. Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis. Eur. J, Clin. Microbiol. 5, 226–231 (1986). https://doi.org/10.1007/BF02013995

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02013995

Keywords

Search

Navigation